Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/34104
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18272/20499 (89%)
Visitors : 16429039      Online Users : 990
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34104


    题名: Chronic Stimulation of the Autophagy-inducing Ingredient of Areca Nut Promotes Tumor Growth In Vivo Through Up-regulation of Tumoral Autophagy
    作者: Chiu, Chang-Ta
    Liu, Shyun-Yeu
    Yen, Ching-Yu
    Liu, Bang-Yen
    Sun, Zi-Yu
    Wu, Chun-Yi
    Deng, Ji-Lung
    Liu, Young-Chau
    Lin, Mei-Huei
    贡献者: China Med Univ, An Nan Hosp, Dept Dent
    Chi Mei Med Ctr, Oral & Maxillofacial Surg Sect
    Taipei Med Univ, Dept Dent
    Natl Def Med Ctr, Dept Dent
    Chia Nan Univ Pharm, Dept Biotechnol
    Chi Mei Med Ctr, Dept Med Res
    Shu Te Univ, Div Nat Sci, Coll Liberal Educ
    关键词: Areca nut
    autophagy
    nude mice
    3-methyladenine
    chloroquine
    cisplatin
    日期: 2020
    上传时间: 2022-11-18 11:24:06 (UTC+8)
    出版者: Int Inst Anticancer Research
    摘要: Background/aim: Autophagy can be either tumor promotive or suppressive. We previously identified an autophagy-inducing activity in the 30-100 kDa fraction of areca-nut-extract (ANE 30-100K) and showed that several tumor cells subjected to chronic ANE 30-100K stimulation (CAS) exhibited higher resistance against stressed environments including serum-free (SF) conditions in vitro. Herein, we aimed to assess whether CAS can also provide growth advantages for tumor cells in vivo and the therapeutic effect of autophagy inhibition on CAS-treated tumors. Materials and Methods: Esophageal CE81T/VGH cells and nude mice were used as experimental models. Autophagy inhibitors 3-methyladenine (3-MA) and chloroquine (CQ), as well as another anticancer drug cisplatin (DDP), were chosen to challenge CAS-treated CE81T/VGH cells in vitro and in vivo. Results: CAS-treated CE81T/VGH cells expressed higher levels of microtubuleassociated protein 1 light chain 3A/B-II (LC3-II) and beclin 1 proteins, and showed stronger resistance to SF and hypoxia conditions, that were mitigated by CQ or 3-MA in vitro. Furthermore, CAS-treated CE81T/VGH cells induced significantly larger tumors in mice, which were also attenuated by single 3-MA or CQ treatment. Finally, the combined treatment of 3-MA or CQ with DDP further upregulated DDP-induced caspase-3 activity in vitro and exhibited synergistic anti-tumor effects on mice. Conclusion: CAS may up-regulate tumoral autophagy and provide growth advantage for tumors both in vitro and in vivo. Furthermore, autophagy inhibition alone or in combination with DDP may achieve positive therapy for tumors encountered with CAS.
    關聯: Anticancer Research, v.40, n.1, pp.7
    显示于类别:[Dept. of Biotechnology (including master's program)] Periodical Articles

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML935检视/开启


    在CNU IR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈